US Patent 11602521 N,N-dimethyltryptamine compositions and methods
Patent 11602521 was granted and assigned to ATAI Life Sciences on March, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11602521 N,N-dimethyltryptamine compositions and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
